Nucleozin targets cytoplasmic trafficking of viral ribonucleoprotein-Rab11 complexes in influenza A virus infection

Journal of Virology

Volumn 87, Issue 8, 2013, Pages 4694-4703

  Amorim, Maria Joao ^a,b   Kao, Richard Y ^c   Digard, Paul ^d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; NUCLEOZIN; RAB11 PROTEIN; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; EMBRYO; HUMAN; HUMAN CELL; INFLUENZA A; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; PROTEIN TRANSPORT; VIRUS INHIBITION; VIRUS RELEASE; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL TRANSPORT; CELL LINE; HUMANS; INFLUENZA A VIRUS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; RAB1 GTP-BINDING PROTEINS; RNA-BINDING PROTEINS; VIRAL CORE PROTEINS; VIRUS REPLICATION;

INFLUENZA A VIRUS;

EID: 84875785705     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03123-12     Document Type: Article

References (51)

1. Jagger BW, Wise HM, Kash JC, Walters KA, Wills NM, Xiao YL, Dunfee RL, Schwartzman LM, Ozinsky A, Bell GL, Dalton RM, Lo A, Efstathiou S, Atkins JF, Firth AE, Taubenberger JK, Digard P. 2012. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 337:199-204.
2. Wise HM, Foeglein A, Sun J, Dalton RM, Patel S, Howard W, Anderson EC, Barclay WS, Digard P. 2009. A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J. Virol. 83:8021-8031.
3. Wise HM, Hutchinson EC, Jagger BW, Stuart AD, Kang ZH, Robb N, Schwartzman LM, Kash JC, Fodor E, Firth AE, Gog JR, Taubenberger JK, Digard P. 2012. Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog. 8:e1002998. doi:10.1371/journal.ppat.1002998.
4. Portela A, Digard P. 2002. The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J. Gen. Virol. 83:723-734.
5. Boulo S, Akarsu H, Ruigrok RW, Baudin F. 2007. Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes. Virus Res. 124: 12-21.
6. Amorim MJ, Bruce EA, Read EK, Foeglein A, Mahen R, Stuart AD, Digard P. 2011. A Rab11- and microtubule-dependent mechanism for cytoplasmic transport o f influenza A virus viral RNA. J. Virol. 85:41434156.
7. Avilov SV, Moisy D, Munier S, Schraidt O, Naffakh N, Cusack S. 2012. Replication-competent influenza A virus that encodes a split-green fluorescent protein-tagged PB2 polymerase subunit allows live-cell imaging of the virus life cycle. J. Virol. 86:1433-1448.
8. Eisfeld AJ, Kawakami E, Watanabe T, Neumann G, Kawaoka Y. 2011. RAB11A is essential for transport of the influenza virus genome to the plasma membrane. J. Virol. 85:6117-6126.
9. Momose F, Sekimoto T, Ohkura T, Jo S, Kawaguchi A, Nagata K, Morikawa Y. 2011. Apical transport o f influenza A virus ribonucleopro- tein requires Rab11-positive recycling endosome. PLoS One 6:e21123. doi:10.1371/journal.pone.0021123.
10. Rossman JS, Lamb RA. 2011. Influenza virus assembly and budding. Virology 411:229-236.
11. Das K, Aramini JM, Ma LC, Krug RM, Arnold E. 2010. Structures of influenza A proteins and insights into antiviral drug targets. Nat. Struct. Mol. Biol. 17:530-538.
12. Huang TS, Palese P, Krystal M. 1990. Determination of influenza virus proteins required for genome replication. J. Virol. 64:5669-5673.
13. Cheng H, Wan J, Lin MI, Liu Y, Lu X, Liu J, Xu Y, Chen J, Tu Z, Cheng YS, Ding K. 2012. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein. J. Med. Chem. 55:2144-2153.
14. Cianci C, Gerritz SW, Deminie C, Krystal M. 26 July 2012. Influenza nucleoprotein: promising target for antiviral chemotherapy. Antivir. Chem. Chemother. (Epub ahead ofprint.) doi:10.3851/IMP2235.
15. Gerritz SW, Cianci C, Kim S, Pearce BC, Deminie C, Discotto L, McAuliffe B, Minassian BF, Shi S, Zhu S, Zhai W, Pendri A, Li G, Poss MA, Edavettal S, McDonnell PA, Lewis HA, Maskos K, Mortl M, Kiefersauer R, Steinbacher S, Baldwin ET, Metzler W, Bryson J, Healy MD, Philip T, Zoeckler M, Schartman R, Sinz M, Leyva-Grado VH, Hoffmann HH, Langley DR, Meanwell NA, Krystal M. 2011. Inhibition o f influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers. Proc. Natl. Acad. Sci. U.S.A. 108:15366-15371.
16. Kao RY, Yang D, Lau LS, Tsui WH, Hu L, Dai J, Chan MP, Chan CM, Wang P, Zheng BJ, Sun J, Huang JD, Madar J, Chen G, Chen H, Guan Y, Yuen KY. 2010. Identification of influenza A nucleoprotein as an antiviral target. Nat. Biotechnol. 28:600-605.
17. Su CY, Cheng TJ, Lin MI, Wang SY, Huang WI, Lin-Chu SY, Chen YH, Wu CY, Lai MM, Cheng WC, Wu YT, Tsai MD, Cheng YS, Wong CH. 2010. High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity. Proc. Natl. Acad. Sci. U. S. A. 107:19151-19156.
18. Carrasco M, Amorim MJ, Digard P. 2004. Lipid raft-dependent targeting o f the influenza A virus nucleoprotein to the apical plasma membrane. Traffic 5:979-992.
19. de Wit E, Spronken MI, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004. Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res. 103:155-161.
20. Matrosovich M, Matrosovich T, Garten W, Klenk HD. 2006. New low-viscosityoverlaymedium forviral plaque assays. Virol. J. 3:63. doi:10 .1186/1743-422X-3-63.
21. Hutchinson EC, Curran MD, Read EK, Gog JR, Digard P. 2008. Mutational analysis o f ds-acting RNA signals in segment 7 o f influenza A virus. J. Virol. 82:11869-11879.
22. Amorim MJ, Read EK, Dalton RM, Medcalf L, Digard P. 2007. Nuclear export of influenza A virus mRNAs requires ongoing RNA polymerase II activity. Traffic 8:1-11.
23. Digard P, Blok VC, Inglis SC. 1989. Complex formation between influenza virus polymerase proteins expressed in Xenopus oocytes. Virology 171:162-169.
24. Poole E, Elton D, Medcalf L, Digard P. 2004. Functional domains of the influenza A virus PB2 protein: identification of NP- and PB1-binding sites. Virology 321:120-133.
25. Noton SL, Medcalf E, Fisher D, Mullin AE, Elton D, Digard P. 2007. Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions. J. Gen. Virol. 88:2280-2290.
26. Loucaides EM, von Kirchbach JC, Foeglein A, Sharps J, Fodor E, Digard P. 2009. Nuclear dynamics of influenza A virus ribonucleoproteins revealed by live-cell imaging studies. Virology 394:154-163.
27. Harman A, Browne H, Minson T. 2002. The transmembrane domain and cytoplasmic tail of herpes simplex virus type 1 glycoprotein H play a role in membrane fusion. J. Virol. 76:10708-10716.
28. Mullin AE, Dalton RM, Amorim MJ, Elton D, Digard P. 2004. Increased amounts of the influenza virus nucleoprotein do not promote higher levels ofviral genome replication. J. Gen. Virol. 85:3689-3698.
29. Read EK, Digard P. 2010. Individual influenza A virus mRNAs show differential dependence on cellular NXF1/TAP for their nuclear export. J. Gen. Virol. 91:1290-1301.
30. Simpson-Holley M, Ellis D, Fisher D, Elton D, McCauley J, Digard P. 2002. A functional link between the actin cytoskeleton and lipid rafts du ring budding offilamentous influenza virions. Virology 301:212-225.
31. Robb NC, Smith M, Vreede FT, Fodor E. 2009. NS2/NEP protein regulates transcription and replication o f the influenza virus RNA genome. J. Gen. Virol. 90:1398-1407.
32. Bruce EA, Medcalf L, Crump CM, Noton SL, Stuart AD, Wise HM, Elton D, Bowers K, Digard P. 2009. Budding of filamentous and nonfilamentous influenza A virus occurs via a VPS4 and VPS28-independent pathway. Virology 390:268-278.
33. Breitenfeld PM, Schafer W. 1957. The formation of fowl plague virus antigens in infected cells, as studied with fluorescent antibodies. Virology 4:328-345.
34. Elton D, Amorim MJ, Medcalf L, Digard P. 2005. 'Genome gating'; polarized intranuclear trafficking of influenza virus RNPs. Biol. Lett. 1:113-117.
35. Bard F, Malhotra V. 2006. The formation ofTGN-to-plasma-membrane transport carriers. Annu. Rev. Cell Dev. Biol. 22:439-455.
36. Gonnord P, Blouin CM, Lamaze C. 2012. Membrane trafficking and signaling: two sides of the same coin. Semin. Cell Dev. Biol. 23:154-164.
37. Hsu VW, Prekeris R. 2010. Transport at the recycling endosome. Curr. Opin. Cell Biol. 22:528-534.
38. Bruce EA, Digard P, Stuart AD. 2010. The Rab11 pathway is required for influenzaAvirus budding and filament formation. J. Virol. 84:5848-5859.
39. Droebner K, Pleschka S, Ludwig S, Planz O. 2011. Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo. Antiviral Res. 92:195-203.
40. Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, Ludwig S. 2001. Influenza virus propagation is impaired by inhibition of the Raf/ MEK/ERK signalling cascade. Nat. Cell Biol. 3:301-305.
41. Wan Y, Yang Z, Guo J, Zhang Q, Zeng L, Song W, Xiao Y, Zhu X. 2012. Misfolded Gbeta is recruited to cytoplasmic dynein by Nudel for efficient clearance. Cell Res. 22:1140-1154.
42. Chen BJ, Leser GP, Morita E, Lamb RA. 2007. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J. Virol. 81:7111-7123.
43. Rossman JS, Jing X, Leser GP, Lamb RA. 2010. Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell 142:902913.
44. Yondola MA, Fernandes F, Belicha-Villanueva A, Uccelini M, Gao Q, Carter C, Palese P. 2011. Budding capability o f the influenza virus neuraminidase can be modulated by tetherin. J. Virol. 85:2480-2491.
45. de Wit E, Spronken MI, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2006. Evidence for specific packaging ofthe influenza A virus genome from conditionally defective virus particles lacking a polymerase gene. Vaccine 24:6647-6650.
46. Fujii Y, Goto H, Watanabe T, Yoshida T, Kawaoka Y. 2003. Selective incorporation o f influenza virus RNA segments into virions. Proc. Natl. Acad. Sci. U. S. A. 100:2002-2007.
47. Muramoto Y, Takada A, Fujii K, Noda T, Iwatsuki-Horimoto K, Watanabe S, Horimoto T, Kida H, Kawaoka Y. 2006. Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J. Virol. 80:2318-2325.
48. Chambers R, Takimoto T. 2010. Trafficking o f Sendai virus nucleocapsids is mediated by intracellular vesicles. PLoS One 5:e10994. doi:10.1371 /journal.pone.0010994.
49. Utley TJ, Ducharme NA, Varthakavi V, Shepherd BE, Santangelo PJ, Lindquist ME, Goldenring JR, Crowe JE, Jr. 2008. Respiratory syncytial virus usesaVps4-independent budding mechanism controlled byRab11- FIP2. Proc. Natl. Acad. Sci. U. S. A. 105:10209-10214.
50. Rowe RK, Suszko JW, Pekosz A. 2008. Roles for the recycling endosome, Rab8, and Rab11 in hantavirus release from epithelial cells. Virology 382: 239-249.
51. Coller KE, Heaton NS, Berger KL, Cooper JD, Saunders JL, Randall G. 2012. Molecular determinants and dynamics ofhepatitis C virus secretion. PLoS Pathog. 8:e1002466. doi:10.1371/journal.ppat.1002466.